RESULTS. In the simple linear regression of retinal vascular caliber on plasma biomarkers, elevated CRP, IL-6, and IP-10 were associated with retinal venular dilation, and elevated KT ratio with retinal arteriolar narrowing. In the multiple linear regression, including baseline characteristics and plasma biomarkers, AMD was associated with dilation of retinal arterioles (mean difference: 9.1 lm; 95% confidence interval [CI] 5.2, 12.9; P < 0.001) and venules (mean difference, 10.9 lm; 95% CI, 5.3, 16.6; P < 0.001), as was black race (P < 0.001). Hyperlipidemia was associated with retinal venular narrowing (mean difference, À7.5 lm; 95% CI, À13.7, À1.2; P ¼ 0.02); cardiovascular disease with arteriolar narrowing (mean difference, À5.2 lm; 95% CI, À10.3, À0.1; P ¼ 0.05); age with arteriolar narrowing (slope, À0.26 lm/year; 95% CI, À0.46, À0.06; P ¼ 0.009); and IL-6 with venular dilation (slope, 5.3 lm/standard deviation log 10 [plasma IL-6 concentration]; 95% CI, 2.7, 8.0; P < 0.001).
H uman immunodeficiency virus (HIV)-infected persons treated with modern antiretroviral therapy (ART) have suppressed HIV replication, reduced amounts of HIV RNA circulating in the blood (HIV viral load), improved immune function typically manifested as a rise in CD4þ T cells (immune recovery), decreased opportunistic infections, and an improved lifespan. [1] [2] [3] [4] Nevertheless, they have a shortened lifespan compared to comparably aged HIV-uninfected persons, largely due to age-related diseases. 5, 6 They have an increase is agerelated diseases such as cardiovascular disease, metabolic disorders (e.g., diabetes and osteoporosis), neurocognitive decline, and age-related cancers not associated with AIDS, [7] [8] [9] [10] suggesting accentuated and accelerated aging. 9, 10 They also exhibit features of immunosenescence, a state characterized by chronic immune activation and systemic inflammation, but a poor response to new antigenic challenges. [9] [10] [11] [12] Compared to HIV-uninfected persons, those with HIV infection have persistently high levels of immune activation and systemic inflammation, despite ART-mediated viral suppression, particularly those who initiate ART at advanced stages of HIV disease. [13] [14] [15] Consistent with this accentuated/accelerated aging, persons with AIDS have an~4-fold increased age-and sex-adjusted prevalence of intermediate-stage AMD compared to HIVuninfected persons 16 and a~1.75-fold increased race/ethnicityand sex-adjusted incidence of intermediate-stage AMD compared to HIV-uninfected persons. 17 Retinal vascular caliber declines with age, and persons with AIDS have retinal arteriolar and venular calibers comparable to HIV-uninfected persons 10 years older. 18 Although a decline in retinal vascular caliber is associated with increasing age, persons with AIDS and AMD have dilated retinal arterioles and venules compared to persons with AIDS without AMD. 19 Retinal venular dilation is associated with systemic inflammation in HIV-uninfected persons. [20] [21] [22] [23] [24] Copyright 2019 The Authors iovs.arvojournals.org j ISSN: 1552-5783
Elevated blood levels of C-reactive protein (CRP) a biomarker of systemic inflammation, are a risk factor for the development of AMD in HIV-uninfected persons, 25 and persons with AMD have elevated blood levels of several proinflammatory cytokines, 26 suggesting that systemic inflammation might be a common pathogenetic factor in both processes. Therefore, we evaluated the relationship between several biomarkers of systemic inflammation and retinal vascular caliber in persons with AIDS enrolled in the Longitudinal Study of the Ocular Complications of AIDS (LSOCA).
PATIENTS AND METHODS
The Longitudinal Study of the Complications of AIDS was a prospective cohort study of patients with the acquired immunodeficiency syndrome conducted in the era of modern ART. 27 Baseline photographs were taken on all participants and evaluated for retinal vascular caliber at the Reading Center in the Department of Ophthalmology and Visual Sciences at the University of Wisconsin, Madison, School of Medicine and Public Health by graders masked as to clinical data, as previously described. 18, 19, 28 As part of a study of AMD, mortality, and biomarkers of systemic inflammation, participants with AMD at enrollment were matched on decade of age, race/ethnicity-, and sex with 2 controls from LSOCA for a case control study, 29 resulting in a study population of 454 persons with AIDS. Retinal vascular indices were determined using previously-described semi-automated methods. Briefly, the six largest arterioles and six largest venules in a ring-shaped area located between 0.5 and 1.0 disc diameters from the edge of the optic nerve were identified. Computer software measured the caliber of the individual vessels, then combined them into two summary measures: the central retinal artery equivalent (CRAE) and central retinal vein equivalent (CRVE). 18, 19, 28 Intermediate-stage AMD was graded at the reading center as previously described. 16, 17, 19, 29 Phlebotomy was performed at enrollment, and plasma specimens cryopreserved. Cryopreserved specimens were thawed and assayed for biomarkers of inflammation using commercially available immunoassay kits in the Core Immunology Laboratories of the University of California, San Francisco, School of Medicine as previously described. 29, 30 Inflammatory biomarkers included high-sensitivity CRP (UBI Magiwel, Mountain View, CA, USA), IL-6 (hsIL-6, R&D Systems, Minneapolis, MN, USA), soluble CD14 (sCD14, R&D Systems), soluble CD163 (sCD163, R&D Systems), and interferon-c inducible protein (IP)-10 (IP-10, R&D Systems), also known as CXCL10. Intestinal fatty acid binding protein (I-FABP), a marker of impaired gut epithelial integrity (R&D Systems), and plasma kynurenine to tryptophan (KT) ratio, a marker of dendritic cell indoleamine 2,3 dioxygenase (IDO) upregulation, 31 also were assessed. The kynurenine tryptophan (KT) ratio was assayed using liquid chromatography-tandem mass spectrometry. 32 
Statistics
Plasma inflammatory biomarker values were log 10 transformed for normality. In order to compare different biomarkers with different dynamic ranges, results were standardized to the standard deviation (SD) units of the log 10 (biomarker plasma level). Testing of the direct association between inflammatory biomarkers and retinal vascular caliber was performed using simple linear regression and the independent association was tested using multiple linear regression with forward selection using a P value for entry 0.05 from a candidate set of 18 variables including the seven plasma biomarkers, AMD status, hyperlipidemia, hypertension, diabetes, cardiovascular disease, elevated creatinine, HIV load, CD4þ T-cell count, CD8þ T-cell count, current use and any prior use of ART. Age, race/ ethnicity, and sex were forced into the model. Similar results were obtained using backward selection and Bayesian Information Criteria (data not shown). Mean central retinal artery equivalent (CRAE) and central retinal vein equivalent (CRVE) were tested across categoric variables at enrollment using ANOVA. Results for categorical variables are expressed as the mean difference in vascular CRAE or CRVE, whereas results for continuous variable are expressed as the slope and 95% confidence interval (CI) of the regression line for CRAE or CRVE (in lm) per standardized unit of the biomarker. P values were nominal and not adjusted for multiple outcomes or multiple looks. The data analyses were generated using statistical software (SAS version 9.4, SAS Institute Inc., Cary, NC, and StataCorp, Release 15; StataCorp LLC, College Station, TX, USA).
RESULTS
Characteristics of the study population are outlined in Table 1 . The relationships between baseline demographic, comorbid disease, HIV treatment, HIV virologic, and immunologic variables and retinal vascular caliber are outlined in Table 2 . Age-related macular degeneration was associated with retinal arteriolar and venular dilation. Older age, male sex, white race, hypertension, cardiovascular disease, receiving ART at enrollment, and elevated HIV load all were associated with retinal arteriolar narrowing. Female sex and black race were associated with retinal venular dilation, whereas hyperlipidemia and receiving ART at enrollment were associated with narrower retinal venules. There were no differences in age by race/ethnicity (mean age: white 47.8 years, black 47.8 years, other 46.8 [P ¼ 0.70 by ANOVA]). There was a difference in the frequency of hypertension by race/ethnicity (proportion with hypertension: white, 23%; black, 30%; other 15% [P ¼ 0.03 by Fisher's exact test]). Although there was a sex difference by race/ethnicity (proportion women: white, 7%; black, 36%; other, 27% [P < 0.001]), the frequency of hypertension did not differ by sex (men, 24%; women, 25%). Overall the rate of hypertension did not vary significantly by race/ethnicity and sex (interaction P value ¼ 0.26). Results of linear regression of CRAE and CRVE versus inflammatory biomarker levels are outlined in Table 3 and Figures 1 and 2 . Venous dilation was significantly associated with the biomarkers CRP, IL-6, and IP-10. The corresponding slopes (95% CI) of CRVE versus plasma biomarker in lm/standard deviation log 10 (plasma biomarker concentration) and P values were: CRP ¼ 3.7 (95 CI ¼ 1.4, 6.0), P ¼ 0.002; IL-6 ¼ 3.7 (95% CI ¼ 1.6, 5.8), P ¼ 0.001; and IP-10 ¼ 2.8 (95% CI ¼ 0.6, 5.0), P ¼ 0.01. Conversely, sCD14, sCD163, KT ratio, and I-FABP were not significantly associated with venular caliber. KT ratio was inversely related to CRAE; the slope was À2.0 (95% CI ¼ À3.6, À0.4), P ¼ 0.02. In the simple linear regression of biomarkers, no other biomarkers were related to CRAE.
In the multiple linear regression of retinal vascular caliber including baseline characteristics and plasma biomarkers (Table 4) , AMD was associated with dilation of retinal arterioles (mean difference 9.1 lm; 95% CI, 5.2, 12.9; P < 0.001) and venules (mean difference 10.9 lm; 95% CI, 5.3, 16.6; P < 0.001). Black race was associated with retinal arteriolar dilation (mean difference vs. white race 9.7 lm; 95% CI, 5.6, 13.8; P < 0.001 and mean difference vs. other race 1.7 lm; 95% CI À3.1, 6.5) and retinal venular dilation (mean difference vs. white race, 12.4 lm; 95% CI, 6.4, 18.4; P < 0.001 and mean difference vs. other race, 6.5 lm; 95% CI À0.5, 13.5).
Hyperlipidemia was associated with retinal venular narrowing (mean difference, À7.5; 95% CI, À13.7, À1.2; P ¼ 0.02). Cardiovascular disease was associated with retinal arteriolar narrowing (mean difference ¼ À5.2 lm; 95% CI À10.3, À0.1; P ¼ 0.05). Age was associated with arteriolar narrowing (slope ¼ À0.26 lm/year; 95% CI, À0.46, -0.06; P ¼ 0.009). Among the inflammatory biomarkers, IL-6 was associated with venular dilation (slope ¼ 5.3 lm/standard deviation log 10 [plasma IL-6 concentration]; 95% CI, 2.7, 8.0; P < 0.001).
As a sensitivity analysis, the multiple linear regression was performed without AMD in the model. The results (Supplemental The total effect of each biomarker on CRAE and CRVE was tested across various subgroups including AMD status, age, sex, and race. There was no evidence of a significant subgroup interaction effect (P < 0.01) although the power to detect these effects is limited (data not shown).
DISCUSSION
Our data suggest that multiple factors are associated with retinal vascular caliber. Increasing age and cardiovascular disease are associated with retinal arteriolar narrowing, and hyperlipidemia is associated with retinal venular narrowing. Black race is associated with both retinal arteriolar and venular dilation. As previously reported, 19 AMD is associated with both retinal arteriolar and retinal venular dilation. The results for the inflammatory biomarkers are more complex. In the simple linear regression, retinal venular dilation was associated with the inflammatory biomarkers CRP, IL-6, and IP-10. In the multiple linear regression, retinal venular dilation was associated only with elevated plasma levels of IL-6. C-reactive protein is an acute phase reactant, which is elevated in several conditions characterized by systemic inflammation, including infection and autoimmune or auto-inflammatory diseases. In animal models, CRP has been reported to inhibit endothelial nitric oxide synthase (eNOS), 33 plausibly contributing to endothelial dysfunction, atherosclerosis, and retinal vascular caliber. Nevertheless, Mendelian randomization studies cast doubt on a direct causal contribution of CRP to cardiovascular disease in man. 34 IL-6 is a proinflammatory cytokine, secreted by several innate immune cells and B-cells, and it is an inducer of CRP synthesis in the liver. 29, 30 The association of retinal venous dilation with both CRP and IL-6 levels in the simple linear regression strengthens the inference that retinal venous dilation is related to systemic inflammation, since these biomarkers are mechanistically linked in vivo. That the association of retinal venular dilation remains associated with IL-6 but not CRP in the multiple linear regression is consistent with the role of IL-6 role as an inducer of CRP. IP-10 is a marker of type I and type II interferon responses typically induced by bacterial or viral infection, and its association with retinal venous dilation suggests that HIV infection or infections with co-pathogens may contribute to this inflammatory state. 29, 30 Elevations of CRP, IL-6, and IP-10 are associated with mortality in persons with HIV infection and AIDS. 29, 30, [35] [36] [37] [38] [39] [40] Elevated IL-6 and CRP levels also predict increased atherosclerosis and an increased risk of incident myocardial infarction in persons with ART-treated HIV infection. [41] [42] [43] [44] Increasing levels of sCD14 and sCD163 are markers of monocyte/macrophage activation, are associated with largevessel atherosclerosis and inflammation, and are associated with an increased risk of mortality in HIV-infected persons, 30, [35] [36] [37] [38] 42, 45, 46 but were not associated with retinal vascular caliber in our study. These results suggest that monocyte/macrophage activation may not contribute substantially to retinal vascular changes in persons with AIDS. Elevation of blood I-FABP level is associated with gut epithelial death or turnover, is linked to microbial translocation, and is associated with AIDS dementia and mortality. 30, 47 Elevated KT ratio is a measure of indoleamine 2,3 dioxygenase (IDO) upregulation, which is induced by interfer- * CRP, C-reactive protein; IL-6, interleukin-6; IP-10, interferon-c inducible protein-10; sCD14, soluble CD14; sCD163, soluble CD163; KT ratio, kynurenine tryptophan ratio; I-FABP, intestinal fatty acid binding protein.
ons and other inflammatory mediators, and results in T cell proliferative defects, loss of gut barrier integrity, and neurotoxicity. 30 Elevations of the KT ratio are associated with increased risks of atherosclerosis and mortality in both HIVinfected and HIV-uninfected persons. 30, [48] [49] [50] Although not associated with CRVE changes, KT ratio was associated with retinal arteriolar narrowing in the simple linear regression, but not the multiple linear regression. Retinal arteriolar narrowing is associated with hypertension and aging in both HIV-infected and HIV-uninfected persons. [18] [19] [20] [21] [22] [23] [24] Caution should be taken in interpreting our results. LSOCA enrolled participants with AIDS and not with earlier stages of HIV infection, so its generalizability to the entire HIV epidemic is uncertain. However, participants enrolled in LSOCA are similar to those with AIDS in the United States, 27 and as such the results should be applicable to patients with AIDS. The data set consisted of 150 participants with AMD matched to 2:1 with age-, sex-, and race/ethnicity-matched controls. The multiple linear regression could only be performed on the subset of participants with results for all 21 candidate variables, resulting in a reduction in the available sample size by approximately one-third. We did not evaluate HIV-uninfected persons. Nevertheless, the inflammatory biomarkers in this study were chosen because they represent immune and 18 Lastly, because only the systemic compartment (plasma) could be sampled, we cannot ascertain the role, if any, of locally-produced (i.e. intraocular) inflammatory mediators on retinal vascular caliber. Nevertheless, these data suggest a potential role for systemic inflammation in retinal vascular caliber, which may be relevant to both HIV-infected and HIV-uninfected persons.
In conclusion, our data demonstrate that retinal arteriolar and venular dilation in patients with AIDS is associated with AMD and with Black race. Age and cardiovascular disease are associated with retinal arteriolar narrowing, and hyperlipidemia with retinal venular narrowing. Elevation of plasma levels of the inflammatory biomarker IL-6, a marker of innate immune system activation and systemic inflammation, is associated 
